Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Study Shows ICD Patients Unaware of Driving Restrictions

By HospiMedica International staff writers
Posted on 10 Sep 2019
Nearly one-third of patients with an implantable cardioverter defibrillator (ICD) resume driving despite it being medically contraindicated, claims a new study.

Researchers at Gentofte University Hospital (Hellerup, Denmark) conducted a study to investigate adherence to driving restrictions among a nationwide cohort of ICD patients. More...
To do so, a questionnaire was sent to 3,913 adults who received a first-time ICD between 2013 and 2016. Additional data was obtained from national registries. Of the 2,741 respondents, 92% had a valid driving license at the time of ICD implantation, and 7% also had a professional driver’s license. In all, more than 30% of ICD patients, including professional drivers, resumed driving during the banned period.

The answers revealed that up to 60% of the patients could not recall being informed of any restriction, and that those who claimed amnesia were three times more likely to drive when banned. Men were 50% more likely to drive while banned, and patients 60 years and older were 20% more likely to drive while banned than younger ICD patients. Being the only driver in the household was linked with a 30% greater likelihood of driving while banned than those who lived with other people who could drive. The study was presented at the annual European Society of Cardiology (ESC) Congress, held during August-September 2019 in Paris (France).

“Information is the key word here. These driving restrictions are worthless if we do not tell patients about them. On the other hand, patients do not remember everything they are told, and if you have recently survived a cardiac arrest, driving restrictions might not be your biggest concern,” said lead author Jenny Bjerre, MD. “Better communication is required, for example by repeating the information, also in writing, explaining the rationale behind the restrictions, and including family members in the discussions.”

The ESC recommends a permanent ban on all professional driving following ICD implantation, and that driving for personal use be banned for four weeks for primary prevention, and three months for secondary prevention; if the ICD delivers a shock to correct an arrhythmia, an additional three-month driving ban is implemented. The penalty for driving while banned depends on national legislation. In Denmark, there is a risk of legal prosecution and/or insurance-related consequences if an ICD patient is involved in a traffic accident during a period with a documented medical driving restriction.

Related Links:
Gentofte University Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.